Date published: 2026-4-20

1-800-457-3801

SCBT Portrait Logo
Seach Input

CLN3 Antibody (C-1): sc-398192

4.3(3)
Write a reviewAsk a question

Datasheets
  • CLN3 Antibody (C-1) is a mouse monoclonal IgG2b κ CLN3 antibody, cited in 1 publications, provided at 200 µg/ml
  • specific for an epitope mapping between amino acids 13-40 at the N-terminus of CLN3 of human origin
  • CLN3 Antibody (C-1) is recommended for detection of CLN3 of mouse, rat and human origin by WB, IP, IF and ELISA
  • Anti-CLN3 Antibody (C-1) is available conjugated to agarose for IP; HRP for WB, IHC(P) and ELISA; and to either phycoerythrin or FITC for IF, IHC(P) and FCM
  • also available conjugated to Alexa Fluor® 488, Alexa Fluor® 546, Alexa Fluor® 594 or Alexa Fluor® 647 for WB (RGB), IF, IHC(P) and FCM, and for use with RGB fluorescent imaging systems, such as iBright™ FL1000, FluorChem™, Typhoon, Azure and other comparable systems
  • also available conjugated to Alexa Fluor® 680 or Alexa Fluor® 790 for WB (NIR), IF and FCM; for use with Near-Infrared (NIR) detection systems, such as LI-COR®Odyssey®, iBright™ FL1000, FluorChem™, Typhoon, Azure and other comparable systems
  • m-IgG Fc BP-HRP, m-IgG2b BP-HRP and m-IgGκ BP-HRP are the preferred secondary detection reagents for CLN3 Antibody (C-1) for WB applications. These reagents are now offered in bundles with CLN3 Antibody (C-1) (see ordering information below).
Gene Editing Promo Banner

QUICK LINKS

SEE ALSO...

CLN3 Antibody (C-1) is a mouse monoclonal IgG2b kappa light chain antibody that detects CLN3 protein of mouse, rat, and human origin by western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), and enzyme-linked immunosorbent assay (ELISA). CLN3 (C-1) antibody is available in both non-conjugated and various conjugated forms, including agarose, horseradish peroxidase (HRP), phycoerythrin (PE), fluorescein isothiocyanate (FITC), and multiple Alexa Fluor® conjugates. CLN3 protein is a highly glycosylated, hydrophobic protein consisting of 438 amino acids and features six transmembrane domains, which are crucial for function in the lysosomal membrane. This localization is significant as CLN3 plays a vital role in lysosomal function, potentially acting as a chaperone that assists in the proper folding and unfolding of other proteins, including subunit C of the ATP synthase complex. Mutations in CLN3 gene are linked to Batten disease, a recessively inherited neurodegenerative disorder characterized by lysosomal accumulation of hydrophobic materials, primarily affecting the ATP synthase subunit C. Batten disease represents the most prevalent form of a group of disorders known as neuronal ceroid lipofuscinoses (NCLs), with symptoms that include progressive vision loss, seizures, and psychomotor disturbances, underscoring the importance of CLN3 protein in maintaining cellular health and function.

For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA

LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences

CLN3 Antibody (C-1) References:

  1. Membrane trafficking and mitochondrial abnormalities precede subunit c deposition in a cerebellar cell model of juvenile neuronal ceroid lipofuscinosis.  |  Fossale, E., et al. 2004. BMC Neurosci. 5: 57. PMID: 15588329
  2. CLN3, the protein associated with batten disease: structure, function and localization.  |  Phillips, SN., et al. 2005. J Neurosci Res. 79: 573-83. PMID: 15657902
  3. Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses.  |  Mole, SE., et al. 2005. Neurogenetics. 6: 107-26. PMID: 15965709
  4. Gene symbol: CLN3. Disease: Juvenile neuronal ceroid lipofuscinosis (Batten disease).  |  Leman, AR., et al. 2005. Hum Genet. 116: 544. PMID: 15991331
  5. Thalamocortical neuron loss and localized astrocytosis in the Cln3Deltaex7/8 knock-in mouse model of Batten disease.  |  Pontikis, CC., et al. 2005. Neurobiol Dis. 20: 823-36. PMID: 16006136
  6. Novel CLN3 mutation predicted to cause complete loss of protein function does not modify the classical JNCL phenotype.  |  Kwon, JM., et al. 2005. Neurosci Lett. 387: 111-4. PMID: 16087292
  7. Cell death pathways in juvenile Batten disease.  |  Persaud-Sawin, DA. and Boustany, RM. 2005. Apoptosis. 10: 973-85. PMID: 16151633

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

CLN3 Antibody (C-1)

sc-398192
200 µg/ml
$322.00

CLN3 Antibody (C-1): m-IgG Fc BP-HRP Bundle

sc-530716
200 µg Ab; 10 µg BP
$361.00

CLN3 Antibody (C-1): m-IgGκ BP-HRP Bundle

sc-524246
200 µg Ab, 40 µg BP
$361.00

CLN3 Antibody (C-1): m-IgG2b BP-HRP Bundle

sc-550217
200 µg Ab; 10 µg BP
$361.00

CLN3 Antibody (C-1) AC

sc-398192 AC
500 µg/ml, 25% agarose
$424.00

CLN3 Antibody (C-1) HRP

sc-398192 HRP
200 µg/ml
$322.00

CLN3 Antibody (C-1) FITC

sc-398192 FITC
200 µg/ml
$336.00

CLN3 Antibody (C-1) PE

sc-398192 PE
200 µg/ml
$349.00

CLN3 Antibody (C-1) Alexa Fluor® 488

sc-398192 AF488
200 µg/ml
$364.00

CLN3 Antibody (C-1) Alexa Fluor® 546

sc-398192 AF546
200 µg/ml
$364.00

CLN3 Antibody (C-1) Alexa Fluor® 594

sc-398192 AF594
200 µg/ml
$364.00

CLN3 Antibody (C-1) Alexa Fluor® 647

sc-398192 AF647
200 µg/ml
$364.00

CLN3 Antibody (C-1) Alexa Fluor® 680

sc-398192 AF680
200 µg/ml
$364.00

CLN3 Antibody (C-1) Alexa Fluor® 790

sc-398192 AF790
200 µg/ml
$364.00

CLN3 (C-1) Neutralizing Peptide

sc-398192 P
100 µg/0.5 ml
$69.00

What application is the blocking peptide sc-398192 P appropriate for?

Asked by: TinTin
Thank you for your question. The blocking peptide is intended for use as a negative control, by pre-adsorbing the mouse monoclonal antibody against the antigen. For full protocol details, please contact our Technical Services Department or view our online protocol here: https://www.scbt.com/scbt/resources/protocols/peptide-neutralization
Answered by: Technical Support
Date published: 2017-02-24
  • y_2026, m_4, d_11, h_10CST
  • bvseo_bulk, prod_bvqa, vn_bulk_3.0.43
  • cp_1, bvpage1
  • co_hasquestionsanswers, tq_1
  • loc_en_US, sid_398192, prod, sort_[SortEntry(order=LAST_APPROVED_ANSWER_SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getContent, 104ms
  • QUESTIONS, PRODUCT
Rated 3 out of 5 by from Bands but not sure of size?This worked for Western Blot as it was showing bands. However, we are not sure if it is specific of the CLN3 size peptides. This also worked with the blocking peptide for CLN3 from Santa Cruz.
Date published: 2017-11-08
Rated 5 out of 5 by from Works very well for westernblotsI applied a sample two weeks ago and detect the CLN3 in HEK293T cells in western blot. It works very well, the band is very clear and specific.
Date published: 2017-04-25
Rated 5 out of 5 by from Very good Western blot data of CLN3 expressionVery good Western blot data of CLN3 expression in HeLa and Jurkat whole cell lysates and human hippocampus and mouse brain tissue extracts. -SCBT QC
Date published: 2013-09-19
  • y_2026, m_4, d_11, h_10
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.43
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_3
  • loc_en_US, sid_398192, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getReviews, 15ms
  • REVIEWS, PRODUCT
CLN3 Antibody (C-1) is rated 4.3 out of 5 by 3.
  • y_2026, m_4, d_11, h_10
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.43
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_3
  • loc_en_US, sid_398192, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getAggregateRating, 175ms
  • REVIEWS, PRODUCT